Background Allergic rhinitis (AR) is an inflammatory disease of the nasal mucosa impacting
up to 25% of Canadians. The standard of care for AR includes a treatment plan that takes …

Allergic rhinitis is a common medical condition characterized by nasal, throat, and ocular
itching; rhinorrhea; sneezing; nasal congestion; and, less frequently, cough. The treatment of …

The selection of specific pharmacotherapy for patients with allergic rhinitis (AR) depends on
several factors, including age, most prominent symptoms, symptom severity, patient …

Purpose Allergic rhinitis is a highly prevalent disease affecting the quality of life of millions of
North Americans. The management of allergic rhinitis includes allergen avoidance …

Allergic rhinitis (AR) and perennial nonallergic rhinitis (PNAR) represent conditions affecting
millions of individuals across the world. Although the diagnosis of AR might be …

Allergen immunotherapy is effective in patients with allergic rhinitis (AR) and, unlike
antiallergic drugs, has been shown to modify the underlying cause of the disease, with …

Allergic rhinitis is a high-cost, high-prevalence disease. In the year 2000, over $6 billion was
spent on prescription medications to treat this illness. Although it is not associated with …

Allergic rhinitis, a common and often debilitating disease marked by rhinorrhea, nasal
congestion, nasal itching, and sneezing, is on the increase worldwide. Treatment involves …

Allergic rhinitis (AR) is one of the most common diseases and represents a global health
problem, currently affecting up to 30% of the general population, with a continuously …

Allergic rhinitis is a burdensome disease for a significant part of the population in both adults
and children. Poorly controlled allergic rhinitis can trigger exacerbations of asthma, sinusitis …